CD24 and lung carcinoma: The monoclonal antibody SWA11 targeting CD24 was injected intraperitoneally into the A549 human lung cancer model (lacking T cells and B cells, and with NK cells without effector function), the BxPC3 pancreatic cancer model (lacking T cells and B cells), and the SKOV3ip ovarian cancer model (lacking T cells), and a reduction in tumour volume was observed in all cases.